Lanzhou Plasma, originated from the Blood Products Department of Lanzhou Institute of Biological Products Co., Ltd, is one of the very first group of blood product manufacturers in China. As early as 1996, it introduced low-temperature ethanol pressure filtration technology from Switzerland into China for the first time, and accumulated profound technical experience in the field of blood product manufacturing ever since. In 2022, it was renamed as "Sinopharm Lanzhou Biopharmaceuticals Co., Ltd".

As a major supplier of blood products in the northwest China, its products have been selected as "Famous Brand Products in Gansu Province" multiple times. Its human albumin and intravenous immunoglobulin were selected for the Gansu Brand Cultivation Catalogue in 2021. In 2019, Lanzhou Plasma was recognized as a high-tech enterprise; In 2021, it was rated as a "Specialized, Refined, Unique, and Innovative" enterprise in Gansu Province; In 2022, it was awarded the title of "Advanced Enterprise in Gansu Province" by the Gansu Provincial Party Committee and Government, and the title of "User Satisfied Enterprise in Gansu Province" by the Gansu Provincial Quality Association, and was rated AA for its market quality credit.